Cargando…

Development of a novel clinical support tool for active surveillance of low risk papillary thyroid cancer

BACKGROUND: Active surveillance (AS) is an alternative to surgery in select patients with very low risk papillary thyroid cancer (PTC). Many clinicians feel ill-equipped in selecting appropriate patients. We aimed to 1) Develop an evidence-based web delivered decision support tool to assist clinicia...

Descripción completa

Detalles Bibliográficos
Autores principales:	White, Eleanor, Abbott, Bridget, Schembri, Geoffrey, Glover, Anthony, Clifton-Bligh, Roderick, Gild, Matti L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520546/ https://www.ncbi.nlm.nih.gov/pubmed/37766695 http://dx.doi.org/10.3389/fendo.2023.1160249

Ejemplares similares

RF11 | PSAT370 I-PET Score: Combining Whole Body Iodine Scan and 18 Fluorodeoxyglucose Positron Emission Topography to Predict Progression in Thyroid Cancer
por: Wijewardene, Ayanthi, et al.
Publicado: (2022)

Medullary Thyroid Cancer: Updates and Challenges
por: Gild, Matti L, et al.
Publicado: (2023)

Translational Utility of Liquid Biopsies in Thyroid Cancer Management
por: Wijewardene, Ayanthi A., et al.
Publicado: (2021)

Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge
por: Gild, Matti L, et al.
Publicado: (2022)

Selpercatinib Treatment of RET-Mutated Thyroid Cancers Is Associated With Gastrointestinal Adverse Effects
por: Tsang, Venessa, et al.
Publicado: (2022)

Thyroid Hormone Abuse Among Elite Athletes
por: Handelsman, David J, et al.
Publicado: (2023)

Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma
por: Kesby, Nicholas, et al.
Publicado: (2023)

Immune Related Adverse Events of the Thyroid – A Narrative Review
por: Muir, Christopher A., et al.
Publicado: (2022)

Lobectomy and completion thyroidectomy rates increase after the 2015 American Thyroid Association Differentiated Thyroid Cancer Guidelines update
por: Worrall, Benjamin J, et al.
Publicado: (2023)

Active Surveillance for Papillary Thyroid Microcarcinoma: Challenges and Prospects
por: Xue, Shuai, et al.
Publicado: (2018)

Infiltrative lymphocytic hypophysitis successfully treated with rituximab and mycophenolate mofetil
por: Lin, Mike, et al.
Publicado: (2020)

Survival outcomes of low-risk papillary thyroid carcinoma at different risk levels: a corollary for active surveillance
por: Ding, Wu, et al.
Publicado: (2023)

Outcomes of nonsuspicious contralateral nodules with active surveillance after lobectomy in patients with papillary thyroid carcinoma
por: Huang, Hui, et al.
Publicado: (2022)

A Protocol for a Pan-Canadian Prospective Observational Study on Active Surveillance or Surgery for Very Low Risk Papillary Thyroid Cancer
por: Sawka, Anna M., et al.
Publicado: (2021)

Papillary Thyroid Carcinoma and Inflammation
por: Fugazzola, Laura, et al.
Publicado: (2011)

Destabilizing RET in targeted treatment of thyroid cancers
por: Gild, M L, et al.
Publicado: (2015)

A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis
por: Fuchs, Talia L., et al.
Publicado: (2020)

Metastatic papillary thyroid cancer to cerebellum with incidental medullary microcarcinoma
por: Wang, Mawson, et al.
Publicado: (2022)

A novel nomogram for identifying high-risk patients among active surveillance candidates with papillary thyroid microcarcinoma
por: Zhang, Li, et al.
Publicado: (2023)

Radioactive iodine in low- to intermediate-risk papillary thyroid cancer
por: Zhao, Hengqiang, et al.
Publicado: (2022)

Development of an Active Surveillance or Surgery Model to Predict Lymph Node Metastasis in cN0 Papillary Thyroid Microcarcinoma
por: Zhang, Huan, et al.
Publicado: (2022)

Thirty synchronous medullary and papillary thyroid carcinomas
por: Zhang, Daqi, et al.
Publicado: (2023)

Appropriate Frequency and Interval of Neck Ultrasonography Surveillance during the First 10 Years after Total Thyroidectomy in Patients with Papillary Thyroid Carcinoma
por: Lee, Yoo Jin, et al.
Publicado: (2018)

Mouse Models of Follicular and Papillary Thyroid Cancer Progression
por: Russo, Marika A., et al.
Publicado: (2012)

The Utility of BRAF Testing in the Management of Papillary Thyroid Cancer
por: Melck, Adrienne L., et al.
Publicado: (2010)

Rethinking the Role of Oncogenes in Papillary Thyroid Cancer Initiation
por: Vitale, Mario
Publicado: (2012)

Ultrasonographic Features of Papillary Thyroid Carcinomas According to Their Subtypes
por: Baek, Hye Jin, et al.
Publicado: (2018)

Oncocytic Adrenocortical Neoplasm with Concomitant Papillary Thyroid Cancer
por: Podetta, Michele, et al.
Publicado: (2018)

Immune Cell Confrontation in the Papillary Thyroid Carcinoma Microenvironment
por: Xie, Zhenyu, et al.
Publicado: (2020)

Molecular Predictors for Advanced Papillary Thyroid Carcinoma Recurrence
por: de Castro, Taciana Padilha, et al.
Publicado: (2019)

Extent of Surgery and the Prognosis of Unilateral Papillary Thyroid Microcarcinoma
por: Zhao, Hengqiang, et al.
Publicado: (2021)

Prognostication of papillary thyroid microcarcinoma based on preoperative ultrasound
por: Cohen, Samuel M., et al.
Publicado: (2023)

TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomas
por: Bullock, Martyn, et al.
Publicado: (2016)

A Novel and Effective Model to Predict Skip Metastasis in Papillary Thyroid Carcinoma Based on a Support Vector Machine
por: Zhu, Shuting, et al.
Publicado: (2022)

Post-surgical Thyroid Bed Pyoderma Gangrenosum Mimicking Recurrent Papillary Thyroid Carcinoma
por: Dolci, Alessia, et al.
Publicado: (2019)

Alterations in the amino acid profile in patients with papillary thyroid carcinoma with and without Hashimoto’s thyroiditis
por: Hellmann, Andrzej, et al.
Publicado: (2023)

Advances in Detecting Low Prevalence Somatic TERT Promoter Mutations in Papillary Thyroid Carcinoma
por: da Costa, Vitor Rodrigues, et al.
Publicado: (2021)

Clinical Outcome, Role of BRAF(V600E), and Molecular Pathways in Papillary Thyroid Microcarcinoma: Is It an Indolent Cancer or an Early Stage of Papillary Thyroid Cancer?
por: Nucera, Carmelo, et al.
Publicado: (2012)

Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA Profiling
por: Galuppini, Francesca, et al.
Publicado: (2022)

The Efficacy and Safety of Radiofrequency Ablation for Bilateral Papillary Thyroid Microcarcinoma
por: Yan, Lin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jv0bgbb0k6146qii6pp3nrn0f5